Bipolar Disorders - Bipolarity - Personality Disorders - Psychosis - Depression - Mania - Hypomania
Register for the International Review of Bipolar Disorders Conference 2012
The European Bipolar Forum

Twitter
Important Deadlines
Bursary Requests
8 December, 2011

Bursary Approvals
4 February, 2012

Early Registration Rate 2
23 February, 2012

Oral Presentation Submissions
23 March, 2012

Poster Submissions
23 March, 2012

Oral Presentation Acceptances
6 April, 2012

IRBD 2012
21-23 May, 2012


A big thank you
At the 2011 conference we had groups of delegates attending from all around the world – we wish to thank the grant funding from the following companies in making this happen and in generating such an opportunity for shared knowledge and global medical education:

Members Login Here

IRBD Conference sponsorship options

Charitable Initiatives

Bipolar Disorders: Clinical and Neurobiological Foundations

Platinum Sponsors
Silver Sponsors
Exhibitors

Oral Session & Poster Submissions

 

Deadlines
Oral Platform Presentations 23 March, 2012
Poster Abstracts 23 March, 2012

 

Individuals are invited to submit poster and oral platform presentations for the conference programme.

The best 6 posters/ oral poster presentations will receive a prize of €300 towards travel and accommodation in 2012 plus FREE registration at IRBD 2013. The deadline for submissions has been extended to Friday 23rd March.

Current Submissions include the following:

  • A tale of two diatheses: temperament and bis/bas as risk factors for mood disorder
  • An adolescent with asperger’s disorder and comorbid bipolar disorder: a case report
  • Bipolar disorder with seasonal pattern: clinical implications in 452 patients.
  • Childhood attachment, parental bonding and bipolar disorder: a review
  • Dextromethorphan induced bipolar disorder
  • Drug treatment of bipolar ii depression during and after pregnancy
  • Efficacy and tolerability of quetiapine xr in bipolar affective disorder
  • Emigration and risk of depression by gender in sardinian studies: does hypomanic temperament play a role?
  • Exploring biomarkers for neurodegenerative processes in the cerebrospinal fluid from bipolar patients
  • Neurocognitive function in bipolar disorder: a comparison between bipolar i and ii disorder and matched controls
  • Parental reports of early psychopathology in children and adolescent with bipolar disorder
  • Rabbit syndrome due to olanzapine in a patient with bipolar disorder
  • Rainbow, psychosocial therapy for pediatric bipolar disorder (pbd):adaptation to portuguese families
  • Regulation of igf-1 expression in the hippocampus by acute peripheral lipopolysaccharide administration in prenatally stressed animals.
  • The effectiveness of brief cognitive psychotherapy in the reduction of patients' depressive symptoms in relation to the number of episodes
  • The impact of mood and anxiety disorders on visual rivalry; a review
  • The risk of bipolar disorders and major depressive disorders in wilson’s disease: results of a case-control study
  • Validation of the mood disorders questionnaire for bipolar disorder in the postpartum period

The oral platforms will consist of 10 minute talks - 8 slides per person with 2 minutes allowed for questions.

Posters will be displayed electronically on monitors in the exhibition area of the conference venue. They should be prepared in Powerpoint and presented in several page formats –  e.g. Introduction and Method on one page, then Results and Conclusion, then supporting data presentations (e.g. up to three charts).  The secretariat prefers posters to be well structured in terms of having a Title, Author, Introduction, Hypothesis, Method, Results, Conclusion/Discussion, however we understand that this cannot always be the case.  Delegates will be able to scroll through the pages to view the poster on the monitors.  For the poster sessions, authors will be able to stand near a monitor to discuss their poster with interested delegates.

Abstracts should be up to 500 words long and will be published in the final programme and abstract book.  Abstracts will also be published in the Journal of International Clinical PsychoPharmacology (ISSN: 1473-5857) 

Please complete all of the fields below and upload a short supporting Biography when making your submission. Please ensure you also include all author names and relevant institutions/organizations.

Receipt of abstracts will acknowledged. If you have any queries regarding the submissions process or a previous submission please contact the IRBD Secretariat (select Contact Us from the menu above).



Please complete the following form to submit your abstract

Personal Details
Fields marked with a * are required in order to submit the form

 Exceeded maximum number of characters.
Invalid format.
Abstract Information
Poster
Oral Presentation
Supporting Biography

Please supply a short Bio/CV (500 words max) to support your Abstract, please use only the following formats: PDF or Word Documents upto 3MB in size (eg filename.doc not file.name.doc)

Human Verification

In order to prevent fraudulent submissions by 'bots' we use a human captcha system, please enter the exact characters (without spaces) you see in the graphic below, in the box provided.

CAPTCHA Image Reload Image

Grants provided by


Page Last Updated : 22-02-2012